Advertisement

Musculoskeletal Manifestations of Systemic Diseases

  • Michael Malekan
  • Apostolos KontziasEmail author
Chapter

Abstract

Musculoskeletal symptoms may be the initial presentation of a wide variety of systemic non-rheumatic conditions to include metabolic, endocrine, hematologic, and malignant process. Epidemiological features such as gender, ethnicity and age of onset, arthritis pattern, and associated symptoms along with response or lack thereof to empiric treatments provide clues to formulate a broad differential diagnosis. Identifying the primary disorder is crucial for prognostic and therapeutic purposes. In older patients, seronegative patients, or patients whose constitutional symptoms are out of proportion to underlying arthritis, evaluation for underlying malignancy is warranted. Early-onset arthritis may be seen in rare genetic disorders like Wilson’s disease or alkaptonuria. Rheumatologic manifestations are common in sarcoidosis but are frequently misdiagnosed or overlooked. Early osteoporosis and osteoarthritis should raise suspicion for systemic conditions. Amyloid deposition can indolently cause musculoskeletal symptoms mimicking classic primary rheumatic diseases.

Keywords

Sarcoidosis Alkaptonuria Wilson’s disease Amyloidosis Metabolic Malignancy Musculoskeletal 

References

  1. 1.
    Chakravarty SD, Markenson JA. Arthritis accompanying endocrine and metabolic disorders. In: Kelley and Firestein’s Textbook of Rheumatology, Firestein GS, Budd RC, Gabriel SE, McInnes IB, O’Dell JR, editors. 10th ed. Elsevier; 2017.Google Scholar
  2. 2.
    Kenanidis E, Kakoulidis P, Lepetsos P, Potoupnis M, Tsiridis E, Toğrul E, et al. Sickle cell disease. In: The Adult Hip – Master Case Series and Techniques, Tsiridis E, editor. 1st ed. Springer; 2018.Google Scholar
  3. 3.
    Griffith JF. Musculoskeletal manifestations of endocrine disease. In: Hodler J, Kubik-Huch R, von Schulthess G, editors. Musculoskeletal diseases. Cham: Springer; 2017.Google Scholar
  4. 4.
    Rogers LC, Frykberg RG. Charcot arthropathy in the diabetic foot. In: The Diabetic Foot-Medical and surgical management, Veves A, Giurini JM, LoGerfo FW, editors. Totowa, NJ: Humana Press; 2012.Google Scholar
  5. 5.
    Olvi LG, Santini-Araujo E. “Brown tumor” of hyperparathyroidism. In: Tumors and Tumor-Like Lesions of Bone, Santini-Araujo E, Kalil RK, Bertoni F, Park YK, editors. 1st ed, Springer; 2015.Google Scholar
  6. 6.
    Quemeneur AS, Trocello JM, Ea HK, Woimant F, Liote F. Miscellaneous non-inflammatory musculoskeletal conditions. Musculoskeletal conditions associated with Wilson’s disease. Best Pract Res Clin Rheumatol. 2011;25(5):627–36.CrossRefGoogle Scholar
  7. 7.
    Gallagher JA, Dillon JP, Sireau N, Timmis O, Ranganath LR. Alkaptonuria: an example of a “fundamental disease”--a rare disease with important lessons for more common disorders. Semin Cell Dev Biol. 2016;52:53–7.CrossRefGoogle Scholar
  8. 8.
    G. C. Hemochromatosis. In: Kelley and Firestein’s Textbook of Rheumatology, Firestein GS, Budd RC, Gabriel SE, McInnes IB, O’Dell JR, editors. 10th ed. Elsevier; 2017.Google Scholar
  9. 9.
    Rodríguez-Merchán EC, De la Corte-García H. Musculoskeletal manifestations of hemophilia. In: Rodríguez-Merchán EC, editor. Joint surgery in the adult patient with hemophilia. Cham: Springer; 2015.CrossRefGoogle Scholar
  10. 10.
    van Vulpen LFD, Roosendaal G, Lafeber FPJG. Hemophilic arthropathy. In: Kelley and Firestein’s Textbook of Rheumatology, Firestein GS, Budd RC, Gabriel SE, McInnes IB, O’Dell JR, editors. 10th ed. Elsevier; 2017.Google Scholar
  11. 11.
    Lozada CJ, Tozman EC. Rheumatic manifestations of hemoglobinopathies. In: Kelley and Firestein’s Textbook of Rheumatology, Firestein GS, Budd RC, Gabriel SE, McInnes IB, O’Dell JR, editors. 10th ed. Elsevier; 2017.Google Scholar
  12. 12.
    Al-Tubaikh JA. β-Thalassemia major (Cooley’s anemia). In: Al-Tubaikh JA, editor. Internal medicine. Berlin, Heidelberg: Springer; 2010.CrossRefGoogle Scholar
  13. 13.
    Dimitriades VR, Sorensen R. Rheumatologic manifestations of primary immunodeficiency diseases. Clin Rheumatol. 2016;35(4):843–50.CrossRefGoogle Scholar
  14. 14.
    Selmi C, Greenspan A, Huntley A, Gershwin ME. Multicentric reticulohistiocytosis: a critical review. Curr Rheumatol Rep. 2015;17(6):511.CrossRefGoogle Scholar
  15. 15.
    Ashouri JF, Daikh DI. Rheumatic manifestations of cancer. Rheum Dis Clin N Am. 2011;37(4):489–505.CrossRefGoogle Scholar
  16. 16.
    Calabrese LH, Calabrese C, Cappelli LC. Rheumatic immune-related adverse events from cancer immunotherapy. Nat Rev Rheumatol. 2018;14(10):569–79.CrossRefGoogle Scholar
  17. 17.
    Vaseer S, Chakravarty EF. Musculoskeletal syndromes in malignancy. In: Kelley and Firestein’s Textbook of Rheumatology, Firestein GS, Budd RC, Gabriel SE, McInnes IB, O’Dell JR, editors. 10th ed. Elsevier; 2017.Google Scholar
  18. 18.
    Perfetto F, Moggi-Pignone A, Livi R, Tempestini A, Bergesio F, Matucci-Cerinic M. Systemic amyloidosis: a challenge for the rheumatologist. Nat Rev Rheumatol. 2010;6(7):417–29.CrossRefGoogle Scholar
  19. 19.
    Sweiss NJ. Sarcoidosis. In: Kelley and Firestein’s Textbook of Rheumatology, Firestein GS, Budd RC, Gabriel SE, McInnes IB, O’Dell JR, editors. 10th ed. Elsevier; 2017.Google Scholar
  20. 20.
    Sweiss NJ, Patterson K, Sawaqed R, Jabbar U, Korsten P, Hogarth K, et al. Rheumatologic manifestations of sarcoidosis. Semin Respir Crit Care Med. 2010;31(4):463–73.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Division of Rheumatology, Immunology and AllergyStony Brook University HospitalStony BrookUSA

Personalised recommendations